Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir

Farmaco

Volumn 55, Issue 4, 2000, Pages 322-327

  Macchia, Marco ^a   Antonelli, Guido ^a   Bertini, Simone ^a   Calvani, Federico ^a   Di Bussolo, Valeria ^a   Minutolo, Filippo ^a   Tesoro, Ramon ^b   Tonetti, Imperio ^a   Turriziani, Ombretta ^b  

^a UNIVERSITY OF PISA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acyclovir diphosphate; Acyclovir monophosphate; Antiviral; HIV 1; HSV 1

Indexed keywords

ACICLOVIR DERIVATIVE; ACICLOVIR DIPHOSPHATE; ACICLOVIR MONOPHOSPHATE; GANCICLOVIR; LAMIVUDINE; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; MOLECULAR STRUCTURE; PHOSPHATES; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 0033842093     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(00)00046-X     Document Type: Article

References (19)

1. Elion G.B., Furman P.A., Fyfe J.A., DeMiranda P., Beauchamp L., Shaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA. 74:1977;5716-5720.
2. Martin J.C., Dvrorak C.A., Smee D.F., Matthews T.R., Verheyden J.P.H. 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. J. Med. Chem. 26:1983;759-761.
3. Mitsuya H., Weinhold K.J., Furman P.A., St Clair M.H., Lehrman S.N., Gallo R.C., Bolognesi D., Barry D.W., Broder S. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA. 82:1985;7096-7100.
4. Coates J.A., Cammack N., Jenkinson H.J., Jowett A.J., Jowett M.I., Pearson B.A., Penn C.R., Rouse P.L., Viner K.C., Cameron J.M. 2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro. Antimicrob. Agents Chemother. 36:1992;733-739.
5. Mansuri M.M., Hitchcock M.J., Buroker R.A., Bregman C.L., Ghazzouli I., Desiderio J.V., Starrett J.E., Sterzycki R.Z., Martin J.C. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus. Antimicrob. Agents Chemother. 34:1990;637-641.
6. Furman P.A., Fyfe J.A., St. Clair M.H., Weinhold K.J., Rideout J.L., Freeman G.A., Nusinoff-Lehrmann S., Bolognesi D.P., Broder S., Mitsuya H., Barry D.W. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA. 83:1986;8333-8337.
7. Balzarini J., Herdewijn P., De Clercq E. Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264:1989;6127-6133.
8. Hao Z., Cooney D.A., Farquhar D., Perno C.F., Zhang K., Masood R., Wilson Y., Hartman N.R., Balzarini J., Johns D.G. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2′,3′-dideoxyuridine-5′-triphosphate. Mol. Pharmacol. 37:1990;157-163.
9. De Clercq E., Holý A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P.C. A novel selective broad-spectrum anti-DNA virus agent. Nature. 323:1986;464-467.
10. Balzarini J., Naesens L., Herdewijn P., Rosenberg I., Holy A., Pauwels R., Baba M., Johns D.G., De Clercq E. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proc. Natl. Acad. Sci. USA. 86:1989;332-336.
11. L.J. Jennings, M. Macchia, A. Parkin, Synthesis of analogues of 5-iodo-2′-deoxyuridine-5′-diphosphate, J. Chem. Soc. Perkin Trans. I (1992) 2197-2202.
12. Macchia M., Martinelli A., Parkin A., Rossello A. Bioisosters of the diphosphate group in activated forms of antiherpes virus agents. A theoretical study. Farmaco. 49:1994;325-332.
13. Macchia M., Jannitti N., Gervasi G., Danesi R. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins. J. Med. Chem. 39:1996;1352-1356.
14. Crick D.C., Andres D.A., Danesi R., Macchia M., Waechter C.J. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells. J. Neurochem. 70:1998;2397-2405.
15. Gesi M., Pellegrini A., Soldani P., Lenzi P., Paparelli A., Danesi R., Nardini D., Macchia M. Ultrastractural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA Paca-2 pancreatic cancer cells. Ultrastruct. Pathol. 22:1998;253-261.
16. Macchia M., Antonelli G., Calvani F., Di Bussolo V., Minutolo F., Orlandini E., Tesoro R., Turriziani O. Synthesis and antiviral properties of 9-[(2-methyleneaminoxyethoxy)methyl]guanine derivatives as novel acyclovir analogues. Farmaco. 55:2000;104-108.
17. B.D. Davis, R. Dulbecco, H.N. Eisen, H.S. Ginsberg, J.B., Microbiology, fourth ed., Lippincott, Philadelphia, 1990, p. 793.
18. Claphman P.R., Weiss R.A., Dalgleish A.G., Exley M., Whitby D., Hogg N. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology. 158:1987;44-51.
19. Dianzani F., Capobianchi M.R., Antonelli G., Amicucci P., De Marco F. Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction. Antivir. Res. 1:1989;299-306.